KAYLA STAFFORD: Open Payments
NPI 1396580643 · CANTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$743 in 38 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $283 · 2025 $743
Food & beverage: $743
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $359 |
| Novo Nordisk Inc | 6 | $102 |
| Sumitomo Pharma America, Inc. | 2 | $75 |
| AstraZeneca Pharmaceuticals LP | 3 | $61 |
| Astellas Pharma US Inc | 1 | $30 |
| Dynavax Technologies Corporation | 1 | $25 |
| Boston Scientific Corporation | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Lilly USA, LLC | 1 | $16 |
| Currax Pharmaceuticals LLC | 1 | $15 |
Products named: VRAYLAR, GEMTESA, Wegovy, FARXIGA, Ozempic, Veozah, Heplisav-B, General - Pain Management.
Industry payments across GA — which companies pay providers there.
